PER
Click for more information
0.00% 8.0¢ percheron therapeutics limited

News: ANP Antisense Therapeutics says FDA lifts hold for multiple sclerosis drug study

  1. Hot News
    191,110 Posts.
    lightbulb Created with Sketch. 2800
    clock Created with Sketch.
    02/10/17
    10:15
    Post #: 27589158

    Oct 2 (Reuters) - Antisense Therapeutics Ltd (ANP) :

    • Advised by FDA that full clinical hold for phase IIb clinical study of ATL1102 for multiple sclerosis has been lifted
    • Co's application to conduct clinical trial of ATL1102 has been approved by Human Research Ethics Committee
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

ASL Andean discovers up to 4,649 AgEq through maiden drilling in Chile
right-arrow Created with Sketch.
RIO Rio registers 2% drop in iron ore production in 2nd quarter of 2024
right-arrow Created with Sketch.
EVN Evolution shares up 3% on quarterly results for June showing rise in gold production
right-arrow Created with Sketch.
NEWS AI stocks: What to expect in 2024-25
right-arrow Created with Sketch.
ENR Encounter sniffs 4% niobium across 1.6km of strike in WA
right-arrow Created with Sketch.
MEU Marmota hopes to punch through the ceiling of a high-grade system at Goolagong – geology willing
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $72.12M
Open High Low Value Volume
7.9¢ 8.0¢ 7.9¢ $12.63K 158.7K

Buyers (Bids)

No. Vol. Price($)
2 66500 7.6¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 273231 2
View Market Depth
Last trade - 15.26pm 19/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.